To evaluate the efficacy and safety of Escherichia coli Nissle 1917 (EcN) in association with levofloxacin in patients with chronic bacterial prostatitis (CBP).
Patients with CBP referred to our clinic from September 2017 to July 2019 were enrolled.
To evaluate the efficacy and safety of Escherichia coli Nissle 1917 (EcN) in association with levofloxacin in patients with chronic bacterial prostatitis (CBP).
Patients with CBP referred to our clinic from September 2017 to July 2019 were enrolled.